Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
This bill amends section 1833(dd) of the Social Security Act to eliminate the Medicare beneficiary coinsurance requirement for certain colorectal cancer screening tests. The changes in the bill revise the payment/coinsurance language so that Medicare payment percentages are adjusted (noting language that provides 85 percent through 2026 and 100 percent in subsequent years) and removes timing language in the existing provision.
Extent of federal cost versus beneficiary access: liberals prioritize access and view coinsurance elimination as low-barrier prevention; conservatives emphasize fiscal costs and precedent.
Relative to its intended legislative type, this bill is a narrowly scoped substantive amendment to Medicare payment rules with a clear stated purpose and direct edits to the relevant statutory subsection, but it provides limited drafting clarity and little ancillary implementation, fiscal, or oversight detail.
This bill amends section 1833(dd) of the Social Security Act to eliminate the Medicare beneficiary coinsurance requirement for certain colorectal cancer screening tests.
The changes in the bill revise the payment/coinsurance language so that Medicare payment percentages are adjusted (noting language that provides 85 percent through 2026 and 100 percent in subsequent years) and removes timing language in the existing provision.
The overall purpose is to remove or reduce out-of-pocket coinsurance for specified colorectal cancer screening services furnished under the Medicare program.
On content alone, this is a narrow, administratively straightforward expansion of preventive coverage with low political controversy and likely bipartisan sympathy, which increases the chances of enactment. The main constraints are modest but real fiscal effects on Medicare and potential procedural hurdles in the Senate (and the need for a companion Senate measure). Absence of offsets or further legislative packaging could slow or complicate final passage.
Relative to its intended legislative type, this bill is a narrowly scoped substantive amendment to Medicare payment rules with a clear stated purpose and direct edits to the relevant statutory subsection, but it provides limited drafting clarity and little ancillary implementation, fiscal, or oversight detail.
Extent of federal cost versus beneficiary access: liberals prioritize access and view coinsurance elimination as low-barrier prevention; conservatives emphasize fiscal costs and precedent.
These are examples from the analysis, not a ranked list of the most-affected groups.
Extent of federal cost versus beneficiary access: liberals prioritize access and view coinsurance elimination as low-barrier prevention; conservatives emphasize fiscal costs and precedent.
A mainstream progressive would view this bill positively as a targeted, pro-prevention change that reduces out-of-pocket barriers to an evidence-based cancer screening.
They would see eliminating coinsurance for colorectal cancer screening as likely to increase uptake among Medicare beneficiaries, particularly lower-income and medically underserved populations, and as consistent with efforts to reduce health disparities.
They would note that screening and early detection can save lives and potentially reduce later high-cost care.
A pragmatic moderate would generally favor removing financial barriers to an evidence-based preventive service but would want clear information on fiscal effects and implementation details.
They would see merit in reducing coinsurance to encourage screening while asking for cost estimates, offsetting mechanisms, and safeguards against unintended billing gaps.
The centrist would weigh preventive benefits against near-term Medicare outlays and prefer clear statutory language to avoid disputes about which procedures are coin‑free.
A mainstream conservative would be skeptical of any change that increases federal spending or expands entitlement generosity without offsets.
They might acknowledge that preventive care can be beneficial, but they would press for evidence that eliminating coinsurance will lower net Medicare costs rather than increase utilization and spending.
They would also be concerned about statutory vagueness, potential expansion of mandates to Medicare Advantage, and precedent for removing cost-sharing.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a narrow, administratively straightforward expansion of preventive coverage with low political controversy and likely bipartisan sympathy, which increases the chances of enactment. The main constraints are modest but real fiscal effects on Medicare and potential procedural hurdles in the Senate (and the need for a companion Senate measure). Absence of offsets or further legislative packaging could slow or complicate final passage.
The bill has not accumulated any surfaced votes yet.
Extent of federal cost versus beneficiary access: liberals prioritize access and view coinsurance elimination as low-barrier prevention; co…
On content alone, this is a narrow, administratively straightforward expansion of preventive coverage with low political controversy and li…
Relative to its intended legislative type, this bill is a narrowly scoped substantive amendment to Medicare payment rules with a clear stated purpose and direct edits to the relevant statutory subsection, but it provide…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.